Novartis
The Risk-Based Quality Management (RBQM) Risk Surveillance Lead drives the adoption of RBQM practices at the trial level, overseeing the implementation and continuous improvement of quality risk governance. This role involves facilitating risk assessments across clinical domains, monitoring aggregate trial data to identify emerging risks, and leading cross-functional teams to implement mitigation strategies for comprehensive clinical quality.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
Novartis didn’t post a salary, so this is our estimate from similar listings.
Risk Surveillance Lead
ICON plc
Risk Surveillance Lead
Diversity Employment
Clinical Data Risk Manager - LATAM - Remote
ICON plc
Associate Director, Risk-Based Quality Management (RBQM Lead)
Summit Therapeutics,
Associate Director, Quality Risk Specialist
Bristol Myers Squibb
Sr. Manager. Clinical Trial Risk Analyst
Bristol Myers Squibb